There is experimental evidence in support of this hypothesis from mouse models17,33-35 as well as clinical epidemiologic studies showing that FLG null mutations are a risk factor for asthma only in the subtype of asthma that is associated with AD.10 The gene discussed is FLG; the disease is asthma.